Share:

ACOG in the News: Home Births, Pregnancy Drug Safety, IUDs, and Transgender Pregnancy

Home Births, Pregnancy Drug Safety, IUDs, and Transgender Pregnancy

ACOG’s Media Relations team fields 1,500 media inquiries per year. Here are a few of the articles in November and December that prominently featured ACOG guidance and experts:

  • Nocturia: Full Bladder May Get a Third of Women over 40 up at Night

    This article, published online in U.S. News & World Report on December 9, reported on a study in the January 2015 issue of the Green Journal: “Researchers found that of over 2,000 women aged 40 and up, one-third said they routinely got up at least twice a night to use the bathroom. Doctors refer to that as nocturia, and it can be a sign that you’re drinking too much tea or coffee at night—or a signal of a serious health condition.”

     

  • Dense Breasts:  For Women with Dense Breasts, More Mammograms May Not Be the Answer

    This AP article, picked up by Huffington Post on December 9, reports: “More women are learning their breasts are so dense that it’s more difficult for mammograms to spot cancer. But new research suggests automatically giving them an extra test isn’t necessarily the solution. … The American College of Obstetricians and Gynecologists doesn’t recommend routine additional testing in women who have no symptoms or other risk factors.”

     

  • Natural Family Planning: Return of the Rhythm Method

    This article, published December 9 on Atlantic.com, reports that “[t]he American College of Obstetricians and Gynecologists said in a statement that, ‘Natural family planning is not as effective as most other methods of birth control. One in four women who use this method become pregnant.’ The organization also said that women who have abnormal bleeding, vaginitis, cervicitis, frequent fevers, or who are on certain medications should not use these methods.”

     

  • Home Births: Are Home Births Better Than Hospital Births?

    This television segment, which aired December 7 on NBC Nightly News, featured an interview with ACOG Vice President of Education Sandra Ann Carson, MD, FACOG, regarding Britain’s new guidelines that advise more home births.

     

  • Pregnancy and Medication Risks: Drug Labels to Clarify Risks During Pregnancy and Lactation

    This Medscape article, published on December 3 (free log-in required), quotes ACOG’s president in praise of the label changes: “‘The FDA’s updated method of presenting information about both risk and benefit will improve the ability of all physicians to treat their pregnant and breastfeeding patients, as well as women who may become pregnant,’ said ACOG President John Jennings, MD, in a news release. ACOG hopes that more detailed labels will spur more research on the effect of prescription drugs on pregnant and breast-feeding women, Dr. Jennings added.” 

    ACOG’s statement supporting the new rules was also covered in The Hill and, when shared on our national Facebook page, reached more than 7,000 people.

                   

  • IUDs and Implants: Why Gynecologists think IUDs Are The Best Contraceptive

    Vox.com published this article on November 24. An excerpt: “Paragard, the copper IUD, ‘releases copper ions in a steady, slow fashion so that the uterine cavity is bathed in those copper ions,’ said Laura MacIsaac, director of the family planning program at Mt. Sinai Hospital in New York. She also helps the American College of Obstetricians and Gynecologists develop policy on birth control methods.”

    When ACOG shared this online article on our national Facebook page, it reached more than 17,000 people. A December 4 article on Vox about implants also did well on Facebook. 

  • Transgender Pregnancy: What It’s Like to Be Pregnant… and Male

On November 10, Yahoo News covered a December 2014 Green Journal study: “Last week, Obedin-Maliver and other researchers from the University of California, San Francisco, released a landmark study examining pregnancy in 41 transgender men, all of whom conceived after they’d transitioned. The scientists analyzed the effects of testosterone treatments on self-reported pregnancy outcomes—as it turned out, there were none (although this topic requires more research)—but they also aimed to explore the psychological experience of pregnancy as a transgender male.”

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998